Bone disorders, hypertension, and mitochondrial toxicity in HIV disease.
Osteonecrosis, osteopenia and osteoporosis, hypertension, and mitochondrial toxicity are among the medical conditions observed in patients with HIV disease. In some cases, these disorders have been associated with antiretroviral therapy or particular antiretroviral agents. In other cases, their etiology remains unclear. Meg D. Newman, MD, discussed data from studies of these conditions and current management approaches at the Clinical Pathway of the Ryan White CARE Act 2002 All Grantee Conference held in Washington, DC, in August 2002.
Newman
Meg D
MD
University of California San Francisco and UCSF Positive Health Program, San Francisco General Hospital, USA.
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000209:etiology*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D028361:Mitochondrial Diseases / Q000175:diagnosis / Q000209:etiology*; D010020:Osteonecrosis / Q000175:diagnosis / Q000209:etiology*; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology*; D012307:Risk Factors
D019380:Anti-HIV Agents; D000959:Antihypertensive Agents